Animals and Research

I was disappointed to see that The Scientist published the misrepresentative view of animal experimentation expressed in the letter by Melissa Goldman [Feb. 18, 1991, page 12]. It should be noted that both the California Medical Association and the American Medical Association have voted to censure the group Goldman represents, Physicians Committee for Responsible Medicine, for misrepresentation. Goldman claims that leading cosmetics companies have stopped using toxicity testing in animals, pr

Written byCharles Turner
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I was disappointed to see that The Scientist published the misrepresentative view of animal experimentation expressed in the letter by Melissa Goldman [Feb. 18, 1991, page 12]. It should be noted that both the California Medical Association and the American Medical Association have voted to censure the group Goldman represents, Physicians Committee for Responsible Medicine, for misrepresentation.

Goldman claims that leading cosmetics companies have stopped using toxicity testing in animals, presumably because animal testing is ineffective. This claim is misleading. Under Food and Drug Administration regulations, companies that do not use laboratory animal testing, or whose suppliers do not, won't be able to introduce products with innovative ingredients unless their packaging conspicuously states: "Warning: The safety of this product has not been determined." However, most existing ingredients used in the cosmetics industry have been tested on animals by someone, somewhere, at some time. Companies can use these pretested ingredients without ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies